Insulin-Producing Cells Differentiated from Human Bone Marrow Mesenchymal Stem Cells In Vitro Ameliorate Streptozotocin-Induced Diabetic Hyperglycemia.

PubWeight™: 0.76‹?›

🔗 View Article (PMID 26756576)

Published in PLoS One on January 12, 2016

Authors

Ying Xin1,2, Xin Jiang3, Yishu Wang1, Xuejin Su1, Meiyu Sun1, Lihong Zhang1, Yi Tan2, Kupper A Wintergerst2, Yan Li4, Yulin Li1

Author Affiliations

1: Key Laboratory of Pathobiology, Ministry of Education, Jilin University, Changchun, China.
2: Department of Pediatrics, Division of Endocrinology, University of Louisville, Wendy L. Novak Diabetes Care Center, Louisville, Kentucky, United States of America.
3: Department of Radiation Oncology, The First Hospital of Jilin University, Changchun, China.
4: Department of Orthopedic Surgery, Karolinska University Hospital, Stockholm, Sweden.

Articles cited by this

Multilineage potential of adult human mesenchymal stem cells. Science (1999) 66.19

The versatility and universality of calcium signalling. Nat Rev Mol Cell Biol (2000) 19.46

Five-year follow-up after clinical islet transplantation. Diabetes (2005) 7.86

Compensatory growth of pancreatic beta-cells in adult rats after short-term glucose infusion. Diabetes (1989) 3.16

Mechanisms regulating epithelial stratification. Annu Rev Cell Dev Biol (2007) 2.47

Insulin staining of ES cell progeny from insulin uptake. Science (2003) 2.46

Immunosuppressive properties of mesenchymal stem cells: advances and applications. Curr Mol Med (2012) 2.19

Generation of insulin-producing cells from human bone marrow mesenchymal stem cells by genetic manipulation. Stem Cells (2007) 1.85

Differentiation of bone marrow-derived mesenchymal stem cells from diabetic patients into insulin-producing cells in vitro. Chin Med J (Engl) (2007) 1.35

Characterization of Ca(2+) signaling pathways in human mesenchymal stem cells. Cell Calcium (2002) 1.33

Characterization of ionic currents in human mesenchymal stem cells from bone marrow. Stem Cells (2005) 1.32

Artifactual insulin release from differentiated embryonic stem cells. Diabetes (2004) 1.22

Human bone marrow mesenchymal stem cells differentiate into insulin-producing cells upon microenvironmental manipulation in vitro. Differentiation (2009) 1.22

Inducing embryonic stem cells to differentiate into pancreatic beta cells by a novel three-step approach with activin A and all-trans retinoic acid. Stem Cells (2005) 1.20

In vitro trans-differentiation of rat mesenchymal cells into insulin-producing cells by rat pancreatic extract. Biochem Biophys Res Commun (2005) 1.16

Chromosomal variability of human mesenchymal stem cells cultured under hypoxic conditions. J Cell Mol Med (2012) 1.05

Targeting the CXCR4-CXCL12 axis mobilizes autologous hematopoietic stem cells and prolongs islet allograft survival via programmed death ligand 1. J Immunol (2010) 1.04

Stem cell and gene therapies for diabetes mellitus. Nat Rev Endocrinol (2010) 1.03

Reversal of hyperglycemia in diabetic rats by portal vein transplantation of islet-like cells generated from bone marrow mesenchymal stem cells. World J Gastroenterol (2007) 1.03

Immunological and regenerative properties of cord blood stem cells. Clin Immunol (2010) 1.01

Protective effect of FGF21 on type 1 diabetes-induced testicular apoptotic cell death probably via both mitochondrial- and endoplasmic reticulum stress-dependent pathways in the mouse model. Toxicol Lett (2013) 0.99

Nicotinamide in type 1 diabetes. Mechanism of action revisited. Diabetes Care (1999) 0.98

Protection of rat pancreatic islet function and viability by coculture with rat bone marrow-derived mesenchymal stem cells. Cell Death Dis (2010) 0.98

Insulin-producing cells from adult human bone marrow mesenchymal stem cells control streptozotocin-induced diabetes in nude mice. Cell Transplant (2012) 0.98

Molecular and functional expression of voltage-operated calcium channels during osteogenic differentiation of human mesenchymal stem cells. J Bone Miner Res (2005) 0.98

High efficient isolation and systematic identification of human adipose-derived mesenchymal stem cells. J Biomed Sci (2011) 0.97

Generation of glucose-responsive, insulin-producing cells from human umbilical cord blood-derived mesenchymal stem cells. Cell Transplant (2011) 0.92

In vitro generation of glucose-responsive insulin producing cells using lentiviral based pdx-1 gene transduction of mouse (C57BL/6) mesenchymal stem cells. Biochem Biophys Res Commun (2013) 0.87

Evaluation of islets derived from human fetal pancreatic progenitor cells in diabetes treatment. Stem Cell Res Ther (2013) 0.87

Co-transplantation of autologous MSCs delays islet allograft rejection and generates a local immunoprivileged site. Acta Diabetol (2015) 0.86

Effects of lipopolysaccharides on calcium homeostasis in isolated pancreatic acinar cells of rat. Acta Pharmacol Sin (2003) 0.86

GFOGER-modified MMP-sensitive polyethylene glycol hydrogels induce chondrogenic differentiation of human mesenchymal stem cells. Tissue Eng Part A (2014) 0.84

Voltage-operated calcium channel heterogeneity in pancreatic beta cells: physiopathological implications. J Bioenerg Biomembr (2003) 0.83

Alternative splicing targeting the hTAF4-TAFH domain of TAF4 represses proliferation and accelerates chondrogenic differentiation of human mesenchymal stem cells. PLoS One (2013) 0.83

Generation of functional insulin-producing cells from neonatal porcine liver-derived cells by PDX1/VP16, BETA2/NeuroD and MafA. PLoS One (2013) 0.83

Role of injured pancreatic extract promotes bone marrow-derived mesenchymal stem cells efficiently differentiate into insulin-producing cells. PLoS One (2013) 0.82

[Mesenchymal stem cells transduced by PLEGFP-N1 retroviral vector maintain their biological features and differentiation]. Chin Med J (Engl) (2005) 0.80

Reprogramming of bone marrow-derived mesenchymal stem cells into functional insulin-producing cells by chemical regimen. Am J Stem Cells (2012) 0.79

Mechanism of insulin production in canine bone marrow derived mesenchymal stem cells. Gen Comp Endocrinol (2013) 0.78

In vitro (re)programming of human bone marrow stromal cells toward insulin-producing phenotypes. Pediatr Diabetes (2009) 0.78